99% Savings - Buy Just @1 Rs X
Mirabig S 25 Tablet ER (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Mirabig S 25 Tablet ER (10) safe for pregnant women?
Mirabig S Tablet may have some side effects during pregnancy. Pregnant women should discontinue the use of Mirabig S Tablet, and talk to their doctor, if they notice any discomfort.
Is the use of Mirabig S 25 Tablet ER (10) safe during breastfeeding?
Mirabig S Tablet can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Mirabig S 25 Tablet ER (10) on the Kidneys?
Mirabig S Tablet has very mild side effects on the kidneys.
What is the effect of Mirabig S 25 Tablet ER (10) on the Liver?
Very few cases of side effects of Mirabig S Tablet on the liver have been reported.
What is the effect of Mirabig S 25 Tablet ER (10) on the Heart?
Mirabig S Tablet has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Mirabig S 25 Tablet ER (10) unless your doctor advises you to do so -
Is this Mirabig S 25 Tablet ER (10) habit forming or addictive?
No, you will not get addicted to Mirabig S 25 Tablet ER (10).
Interaction between Food and Mirabig S 25 Tablet ER (10)
It is safe to take Mirabig S 25 Tablet ER (10) with food.
Interaction between Alcohol and Mirabig S 25 Tablet ER (10)
Taking alcohol with Mirabig S 25 Tablet ER (10) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 864
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Myrbetriq (mirabegron)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Betmiga® (mirabegron)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; VESIcare® (solifenacin succinate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1151